These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 8635039)

  • 21. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
    González Barón M; Chacón JI; García Girón C; Ordóñez Gallego A; García de Paredes ML; Feliu J; Zamora P; Herranz C; Garrido P; Artal A
    Acta Oncol; 1991; 30(5):623-7. PubMed ID: 1892680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
    J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Roila F; Basurto C; Bracarda S; Picciafuoco M; Ballatori E; Del Favero A; Tonato M
    Oncology; 1990; 47(5):415-7. PubMed ID: 2216296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
    Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S
    J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
    Herrstedt J; Hannibal J; Hallas J; Andersen E; Laursen LC; Hansen M
    Ann Oncol; 1991 Mar; 2(3):223-7. PubMed ID: 2043493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
    Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
    Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
    Cagnoni PJ; Matthes S; Day TC; Bearman SI; Shpall EJ; Jones RB
    Bone Marrow Transplant; 1999 Jul; 24(1):1-4. PubMed ID: 10435726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy.
    Morgan RJ; Synold T; Carr BI; Doroshow JH; Womack EP; Shibata S; Somlo G; Raschko J; Leong L; McNamara M; Chow W; Tetef M; Margolin K; Akman S; Longmate J
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):327-32. PubMed ID: 11345649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antiemetic efficacy of tropisetron plus dexamethasone as compared with conventional metoclopramide-dexamethasone combination in Orientals receiving cisplatin chemotherapy: a randomized crossover trial.
    Chua DT; Sham JS; Au GK; Choy D; Kwong DL; Yau CC; Cheng AC
    Br J Clin Pharmacol; 1996 May; 41(5):403-8. PubMed ID: 8735681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study.
    Molino A; Guglielmo L; Azzolini ME; Biondani P; Capelli MC; Grandinetti A; Griso C; Martinelli G; Martini N; Zanotti R
    Oncology; 1991; 48(2):111-5. PubMed ID: 1997932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
    J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
    Stephens SH; Silvey VL; Wheeler RH
    Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
    Orr LE; McKernan JF; Bloome B
    Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
    Lane M; Smith FE; Sullivan RA; Plasse TF
    Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of metoclopramide, prochlorperazine and placebo in prevention of postoperative nausea and vomiting (PONV) following tonsillectomy in young adults.
    Jamil M; Gilani SM; Khan SA
    J Ayub Med Coll Abbottabad; 2005; 17(4):40-4. PubMed ID: 16599033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.